Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05471622 · ClinicalTrials.gov registry record · NA
Study of Home-Embedded Palliative Care for Hemodialysis-Dependent End-Stage Renal Disease
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 285
- Enrollment target
NCT05471622: Completed NA study, sponsored by University of Pennsylvania.
NCT05471622 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 285 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05471622, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 285 participants
- Enrollment target
Study Summary
Home palliative care needs are often under-recognized in patients with End-Stage Renal Disease (ESRD). This pilot study is designed to evaluate the feasibility and acceptability of an initiative to enhance referrals to Penn Home Palliative Care compared with usual care among hemodialysis-dependent ESRD patients admitted to a Penn hospital. Results will inform a future pragmatic trial comparing the effectiveness of home palliative care compared with usual care among ESRD patients. Evaluating the effectiveness of home palliative care services is critical to determine whether increasing access to these services would improve patient-centered outcomes for these high-need patients.
Interventions
- BEHAVIORAL Nudge for PHPC Referral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2022-07-21 |
| Est. Completion | 2023-12-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05471622
The ClinicalTrials.gov registry entry for NCT05471622 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 285 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nudge for PHPC Referral is the first listed.
NCT05471622 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05471622 about?
NCT05471622 is a clinical study titled "Study of Home-Embedded Palliative Care for Hemodialysis-Dependent End-Stage Renal Disease". Home palliative care needs are often under-recognized in patients with End-Stage Renal Disease (ESRD). This pilot study is designed to evaluate the feasibility and acceptability of an initiative to enhance referrals to Penn Home Palliative Care compared with usual care among hemodialysis-dependent E...
What is the current status of trial NCT05471622?
This trial is currently completed. It is a NA study. The enrollment target is 285 participants. The study started on 2022-07-21. Estimated completion is 2023-12-18.
What interventions are being tested in trial NCT05471622?
The interventions under investigation include: Nudge for PHPC Referral (BEHAVIORAL).
Who is sponsoring clinical trial NCT05471622?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.